LncRNA HOXB-AS3 promotes proliferation, migration, and invasion of gallbladder cancer cells by activating the MEK/ERK pathway
LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC. To know the potential function of HOXB-AS3 in...
Saved in:
| Published in | Heliyon Vol. 10; no. 16; p. e35906 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
30.08.2024
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC.
To know the potential function of HOXB-AS3 in gallbladder carcinoma, real-time polymerase chain reaction was used to detected the expression of HOXB-AS3 in gallbladder carcinoma cells. The colony formation assay and cell counting kit-8 assay was performed to measured cell viability. Flow cytometry was to analyse cell apoptosis and cell cycle. Cell invasion and migration were determined by the transwell invasion assay and wound-healing assay. A nude mice xenograft tumor model was performed to investigate the biological function of HOXB-AS3 in vivo.
The results indicated that HOXB-AS3 was significantly elevated in gallbladder carcinoma tissues and cell lines. We used siHOXB-AS3 to knockdown the expression levels of HOXB-AS3. And knockdown HOXB-AS3 expression depressed gallbladder cancer cell viability and induced cell apoptosis. In addition, the gallbladder carcinoma cell cycle was obviously arrested at the G1 phase. Cell invasion and migration were markedly suppressed following knockdown HOXB-AS3 expression. Furthermore, the features of siHOXB-AS3 in gallbladder cancer cells could be reversed by the ERK1/2 phosphorylation agonist Ro 67–7476. Finally, we confirmed that HOXB-AS3 promoted the growth of transplanted tumors in vivo.
HOXB-AS3 promoted gallbladder carcinoma cell proliferation, invasion and migration by activating the MEK/ERK signaling pathway. HOXB-AS3 contributed to gallbladder cancer tumorigenesis and metastasis, making it a viable therapeutic target for gallbladder cancer treatment. |
|---|---|
| AbstractList | LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC.BackgroundLncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC.To know the potential function of HOXB-AS3 in gallbladder carcinoma, real-time polymerase chain reaction was used to detected the expression of HOXB-AS3 in gallbladder carcinoma cells. The colony formation assay and cell counting kit-8 assay was performed to measured cell viability. Flow cytometry was to analyse cell apoptosis and cell cycle. Cell invasion and migration were determined by the transwell invasion assay and wound-healing assay. A nude mice xenograft tumor model was performed to investigate the biological function of HOXB-AS3 in vivo.MethodsTo know the potential function of HOXB-AS3 in gallbladder carcinoma, real-time polymerase chain reaction was used to detected the expression of HOXB-AS3 in gallbladder carcinoma cells. The colony formation assay and cell counting kit-8 assay was performed to measured cell viability. Flow cytometry was to analyse cell apoptosis and cell cycle. Cell invasion and migration were determined by the transwell invasion assay and wound-healing assay. A nude mice xenograft tumor model was performed to investigate the biological function of HOXB-AS3 in vivo.The results indicated that HOXB-AS3 was significantly elevated in gallbladder carcinoma tissues and cell lines. We used siHOXB-AS3 to knockdown the expression levels of HOXB-AS3. And knockdown HOXB-AS3 expression depressed gallbladder cancer cell viability and induced cell apoptosis. In addition, the gallbladder carcinoma cell cycle was obviously arrested at the G1 phase. Cell invasion and migration were markedly suppressed following knockdown HOXB-AS3 expression. Furthermore, the features of siHOXB-AS3 in gallbladder cancer cells could be reversed by the ERK1/2 phosphorylation agonist Ro 67-7476. Finally, we confirmed that HOXB-AS3 promoted the growth of transplanted tumors in vivo.ResultsThe results indicated that HOXB-AS3 was significantly elevated in gallbladder carcinoma tissues and cell lines. We used siHOXB-AS3 to knockdown the expression levels of HOXB-AS3. And knockdown HOXB-AS3 expression depressed gallbladder cancer cell viability and induced cell apoptosis. In addition, the gallbladder carcinoma cell cycle was obviously arrested at the G1 phase. Cell invasion and migration were markedly suppressed following knockdown HOXB-AS3 expression. Furthermore, the features of siHOXB-AS3 in gallbladder cancer cells could be reversed by the ERK1/2 phosphorylation agonist Ro 67-7476. Finally, we confirmed that HOXB-AS3 promoted the growth of transplanted tumors in vivo.HOXB-AS3 promoted gallbladder carcinoma cell proliferation, invasion and migration by activating the MEK/ERK signaling pathway. HOXB-AS3 contributed to gallbladder cancer tumorigenesis and metastasis, making it a viable therapeutic target for gallbladder cancer treatment.ConclusionHOXB-AS3 promoted gallbladder carcinoma cell proliferation, invasion and migration by activating the MEK/ERK signaling pathway. HOXB-AS3 contributed to gallbladder cancer tumorigenesis and metastasis, making it a viable therapeutic target for gallbladder cancer treatment. LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC. To know the potential function of HOXB-AS3 in gallbladder carcinoma, real-time polymerase chain reaction was used to detected the expression of HOXB-AS3 in gallbladder carcinoma cells. The colony formation assay and cell counting kit-8 assay was performed to measured cell viability. Flow cytometry was to analyse cell apoptosis and cell cycle. Cell invasion and migration were determined by the transwell invasion assay and wound-healing assay. A nude mice xenograft tumor model was performed to investigate the biological function of HOXB-AS3 in vivo. The results indicated that HOXB-AS3 was significantly elevated in gallbladder carcinoma tissues and cell lines. We used siHOXB-AS3 to knockdown the expression levels of HOXB-AS3. And knockdown HOXB-AS3 expression depressed gallbladder cancer cell viability and induced cell apoptosis. In addition, the gallbladder carcinoma cell cycle was obviously arrested at the G1 phase. Cell invasion and migration were markedly suppressed following knockdown HOXB-AS3 expression. Furthermore, the features of siHOXB-AS3 in gallbladder cancer cells could be reversed by the ERK1/2 phosphorylation agonist Ro 67–7476. Finally, we confirmed that HOXB-AS3 promoted the growth of transplanted tumors in vivo. HOXB-AS3 promoted gallbladder carcinoma cell proliferation, invasion and migration by activating the MEK/ERK signaling pathway. HOXB-AS3 contributed to gallbladder cancer tumorigenesis and metastasis, making it a viable therapeutic target for gallbladder cancer treatment. LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC. To know the potential function of HOXB-AS3 in gallbladder carcinoma, real-time polymerase chain reaction was used to detected the expression of HOXB-AS3 in gallbladder carcinoma cells. The colony formation assay and cell counting kit-8 assay was performed to measured cell viability. Flow cytometry was to analyse cell apoptosis and cell cycle. Cell invasion and migration were determined by the transwell invasion assay and wound-healing assay. A nude mice xenograft tumor model was performed to investigate the biological function of HOXB-AS3 in vivo. The results indicated that HOXB-AS3 was significantly elevated in gallbladder carcinoma tissues and cell lines. We used siHOXB-AS3 to knockdown the expression levels of HOXB-AS3. And knockdown HOXB-AS3 expression depressed gallbladder cancer cell viability and induced cell apoptosis. In addition, the gallbladder carcinoma cell cycle was obviously arrested at the G1 phase. Cell invasion and migration were markedly suppressed following knockdown HOXB-AS3 expression. Furthermore, the features of siHOXB-AS3 in gallbladder cancer cells could be reversed by the ERK1/2 phosphorylation agonist Ro 67-7476. Finally, we confirmed that HOXB-AS3 promoted the growth of transplanted tumors in vivo. HOXB-AS3 promoted gallbladder carcinoma cell proliferation, invasion and migration by activating the MEK/ERK signaling pathway. HOXB-AS3 contributed to gallbladder cancer tumorigenesis and metastasis, making it a viable therapeutic target for gallbladder cancer treatment. Background: LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear. Therefore, this study aimed to investigate the biological function of HOXB-AS3 in GBC. Methods: To know the potential function of HOXB-AS3 in gallbladder carcinoma, real-time polymerase chain reaction was used to detected the expression of HOXB-AS3 in gallbladder carcinoma cells. The colony formation assay and cell counting kit-8 assay was performed to measured cell viability. Flow cytometry was to analyse cell apoptosis and cell cycle. Cell invasion and migration were determined by the transwell invasion assay and wound-healing assay. A nude mice xenograft tumor model was performed to investigate the biological function of HOXB-AS3 in vivo. Results: The results indicated that HOXB-AS3 was significantly elevated in gallbladder carcinoma tissues and cell lines. We used siHOXB-AS3 to knockdown the expression levels of HOXB-AS3. And knockdown HOXB-AS3 expression depressed gallbladder cancer cell viability and induced cell apoptosis. In addition, the gallbladder carcinoma cell cycle was obviously arrested at the G1 phase. Cell invasion and migration were markedly suppressed following knockdown HOXB-AS3 expression. Furthermore, the features of siHOXB-AS3 in gallbladder cancer cells could be reversed by the ERK1/2 phosphorylation agonist Ro 67–7476. Finally, we confirmed that HOXB-AS3 promoted the growth of transplanted tumors in vivo. Conclusion: HOXB-AS3 promoted gallbladder carcinoma cell proliferation, invasion and migration by activating the MEK/ERK signaling pathway. HOXB-AS3 contributed to gallbladder cancer tumorigenesis and metastasis, making it a viable therapeutic target for gallbladder cancer treatment. |
| ArticleNumber | e35906 |
| Author | Zhu, Hongquan Liang, Yongling Wu, Jiayan Li, Guolin Chen, Zhiping Wan, Yunle Chen, Qin Yu, Jiandong |
| Author_xml | – sequence: 1 givenname: Jiayan surname: Wu fullname: Wu, Jiayan organization: Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China – sequence: 2 givenname: Jiandong surname: Yu fullname: Yu, Jiandong organization: Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China – sequence: 3 givenname: Hongquan surname: Zhu fullname: Zhu, Hongquan organization: Department of General Surgery, Jiangmen Central Hospital, Jiangmen, 529030, China – sequence: 4 givenname: Zhiping surname: Chen fullname: Chen, Zhiping organization: Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China – sequence: 5 givenname: Yongling surname: Liang fullname: Liang, Yongling organization: Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China – sequence: 6 givenname: Qin surname: Chen fullname: Chen, Qin organization: Department of General Surgery, The Affiliated Wuxi NO.2 People's Hospital, Nanjing Medical University, Wu Xi, 214000, China – sequence: 7 givenname: Guolin surname: Li fullname: Li, Guolin email: liglin@mail.sysu.edu.cn organization: Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China – sequence: 8 givenname: Yunle orcidid: 0000-0003-2130-9800 surname: Wan fullname: Wan, Yunle email: wanyunle@mail.sysu.edu.cn organization: Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39224245$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUk1vEzEQXaEiWkp_AmiPHEjqz92sOKBQBVo1UKmAxM0a2-PE0Wad2pugHPjv7DYJarmU04ztec9P897L7KgJDWbZa0qGlNDifDGcY-23oRkywsQQuaxI8Sw7YYLIwUgIcvSgP87OUloQQqgcFVXJX2THvGJMMCFPst_Txtx-HeeXNz8_DsbfeL6KYRlaTH1Te4cRWh-ad_nSzw4tNDb3zQZSd8qDy2dQ17oGazHmBhrTF6zrlOttDqb1mw7XzPJ2jvmXyfX55PY6X0E7_wXbV9lzB3XCs309zX58mny_uBxMbz5fXYynAyOLsh1IXWooacEqygSUllNuCYjKcUcq7XiBWKEFVnKhLTotpbVQaCu1MKUDzk-zqx2vDbBQq-iXELcqgFf3FyHOFMTWmxoVp7RyI5AIzApWoSYaGaPAZek4d67j-rDjWq31Eq3Bpo1QPyJ9_NL4uZqFjaKUFyXhpGN4u2eI4W6NqVVLn_qNQYNhnToJUlAphRz9xyghrKRV1bO-eajrr6CD193A-92AiSGliE4Z395b2sn0taJE9eFSC7UPl-rDpXbh6tDyH_Thg6dw-3Vh5-_GY1TJeOxCYn1E03YG-CcY_gCB--2q |
| CitedBy_id | crossref_primary_10_3389_fmolb_2025_1540048 |
| Cites_doi | 10.1038/nrg.2015.10 10.1007/s12032-021-01594-8 10.1016/j.molcel.2017.09.015 10.1016/j.tcb.2017.11.008 10.5009/gnl.2012.6.2.172 10.2147/CMAR.S278719 10.1093/nar/gkac1071 10.1042/BSR20190906 10.1016/j.bbrc.2018.03.143 10.1016/j.aohep.2021.100563 10.3892/ol.2017.5893 10.7150/jca.46351 10.1177/03000605211013548 10.1016/j.ijbiomac.2019.01.195 10.1038/s41434-020-00187-w 10.1038/s41580-023-00694-9 10.1001/jamanetworkopen.2023.51502 10.4155/fmc.14.143 10.1016/j.eclinm.2023.101951 10.1155/2015/967472 10.1146/annurev-biochem-051410-092902 10.1002/jcp.29618 10.1038/s41572-022-00398-y 10.1097/SLA.0000000000000728 10.1016/j.cell.2013.02.012 10.1186/s12885-020-07676-6 10.7150/ijbs.65824 10.1038/bjc.2017.165 |
| ContentType | Journal Article |
| Copyright | 2024 The Authors 2024 The Authors. Published by Elsevier Ltd. 2024 The Authors. Published by Elsevier Ltd. 2024 |
| Copyright_xml | – notice: 2024 The Authors – notice: 2024 The Authors. Published by Elsevier Ltd. – notice: 2024 The Authors. Published by Elsevier Ltd. 2024 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1016/j.heliyon.2024.e35906 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic AGRICOLA PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2405-8440 |
| ExternalDocumentID | oai_doaj_org_article_3119f8a5ea2d429eb0be221a357f33ff PMC11367030 39224245 10_1016_j_heliyon_2024_e35906 S2405844024119378 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 457 53G 5VS 6I. AAEDW AAFTH AAFWJ AALRI AAYWO ABMAC ACGFS ACLIJ ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPKN AFPUW AFTJW AGHFR AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV DIK EBS FDB GROUPED_DOAJ HYE KQ8 M~E O9- OK1 ROL RPM SSZ AAYXX CITATION EJD IPNFZ RIG NPM 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c567t-5b7ba71629124a7d313d0a49f3f09bf36ee9eda2734bdefb55dda6bd5b4c7fa33 |
| IEDL.DBID | DOA |
| ISSN | 2405-8440 |
| IngestDate | Wed Aug 27 01:29:19 EDT 2025 Thu Aug 21 18:35:00 EDT 2025 Fri Aug 22 20:33:57 EDT 2025 Fri Jul 11 04:24:19 EDT 2025 Mon Jul 21 05:58:49 EDT 2025 Thu Aug 14 00:00:06 EDT 2025 Thu Apr 24 23:11:25 EDT 2025 Sat Aug 30 17:13:23 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 16 |
| Keywords | LncRNA Long non coding RNA GBC HOXB-AS3 MEK/ERK Gallbladder carcinoma |
| Language | English |
| License | This is an open access article under the CC BY-NC license. 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c567t-5b7ba71629124a7d313d0a49f3f09bf36ee9eda2734bdefb55dda6bd5b4c7fa33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
| ORCID | 0000-0003-2130-9800 |
| OpenAccessLink | https://doaj.org/article/3119f8a5ea2d429eb0be221a357f33ff |
| PMID | 39224245 |
| PQID | 3100271990 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3119f8a5ea2d429eb0be221a357f33ff pubmedcentral_primary_oai_pubmedcentral_nih_gov_11367030 proquest_miscellaneous_3154155458 proquest_miscellaneous_3100271990 pubmed_primary_39224245 crossref_citationtrail_10_1016_j_heliyon_2024_e35906 crossref_primary_10_1016_j_heliyon_2024_e35906 elsevier_sciencedirect_doi_10_1016_j_heliyon_2024_e35906 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-30 |
| PublicationDateYYYYMMDD | 2024-08-30 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-30 day: 30 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Heliyon |
| PublicationTitleAlternate | Heliyon |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Wang, Guo, Xie, Jiang (bib31) 2017; 117 Lin, Yang (bib13) 2018; 28 Li, Zhang, Luo (bib24) 2020; 12 Guo, Bai, Ji, Ma (bib28) 2019; 54 Balakrishnan, Barmpounakis, Demiris, Jah, Spiers, Talukder, Martin, Gibbs, Harper, Huguet, Kosmoliaptsis, Liau, Praseedom, Basu, de Aretxabala, Lendoire, Maithel, Branes, Andersson, Serrablo, Adsay (bib2) 2023; 59 Wang, Liu, Shen, Wang, Zhang, Shen, Suo, Pan, Ming, Ding, Liu (bib20) 2017; 13 Zhang, Jiang, Zhang, Liu, Hu, Chen (bib30) 2019; 128 Stinton, Shaffer (bib3) 2012; 6 Gao, Dai, Yu, Yin, Liao, Huang, Zhou (bib25) 2021; 28 Rinn, Chang (bib10) 2012; 81 Xu, Toyoda, Qi, Morimoto, Hanaki, Iwamoto, Komada, Hirayama (bib18) 2018; 499 Roa, Garcia, Kapoor, Maithel, Javle, Koshiol (bib1) 2022; 8 Yu, Ye, Hu, Lv, Tu, Zhou, Li (bib29) 2015; 7 Quinn, Chang (bib11) 2016; 17 Akhtar, Priya, Jain, Sakhuja, Agarwal, Goyal, Polisetty, Sirdeshmukh, Kar, Gautam (bib5) 2020; 20 Batista, Chang (bib12) 2013; 152 Zhuang, Liu, Li (bib15) 2019; 39 Lazcano-Ponce, Miquel, Munoz, Herrero, Ferrecio, Wistuba, Alonso, Aristi, Nervi (bib4) 2001; 51 Jiang, Kai, Li, Wei, Wang, Wang (bib16) 2020; 235 Fu, Nie, Yin, Xu, Lu (bib26) 2021; 26 Su, Zhang, Zhang, Zheng, Zhu (bib22) 2021; 38 Ferrer, Dimitrova (bib8) 2024 Huang, Chen, Chen, Gao, Zhu, Huang, Hu, Zhu, Yan (bib14) 2017; 68 Liu, Chu, Cai, Wu, Yao, Wu, Yang, Li, Liu, Dong, Gong (bib19) 2020; 11 Lu, Zhang, Song, Lu, Wang, Zhou (bib27) 2021; 11 Feng, Yang, Wang, Li, Hasegawa, Liu, Li (bib21) 2022; 18 Kanthan, Senger, Ahmed, Kanthan (bib7) 2015; 2015 Gbolahan, Zhi, Liu, Shah, Kooby, Alese (bib23) 2024; 7 Frankish, Carbonell-Sala, Diekhans, Jungreis, Loveland, Mudge, Sisu, Wright, Arnan, Barnes, Banerjee, Bennett, Berry, Bignell, Boix, Calvet, Cerdan-Velez, Cunningham, Davidson, Donaldson, Dursun, Fatima, Giorgetti, Giron, Gonzalez, Hardy, Harrison, Hourlier, Hollis, Hunt, James, Jiang, Johnson, Kay, Lagarde, Martin, Gomez, Nair, Ni, Pozo, Ramalingam, Ruffier, Schmitt, Schreiber, Steed, Suner, Sumathipala, Sycheva, Uszczynska-Ratajczak, Wass, Yang, Yates, Zafrulla, Choudhary, Gerstein, Guigo, Hubbard, Kellis, Kundaje, Paten, Tress, Flicek (bib9) 2023; 51 Xing, Sun, Li, Jiang, Jiang, Li, Lv, Shao (bib17) 2021; 49 Shindoh, de Aretxabala, Aloia, Roa, Roa, Zimmitti, Javle, Conrad, Maru, Aoki, Vigano, Ribero, Kokudo, Capussotti, Vauthey (bib6) 2015; 261 Xu (10.1016/j.heliyon.2024.e35906_bib18) 2018; 499 Lin (10.1016/j.heliyon.2024.e35906_bib13) 2018; 28 Wang (10.1016/j.heliyon.2024.e35906_bib31) 2017; 117 Huang (10.1016/j.heliyon.2024.e35906_bib14) 2017; 68 Quinn (10.1016/j.heliyon.2024.e35906_bib11) 2016; 17 Gao (10.1016/j.heliyon.2024.e35906_bib25) 2021; 28 Lazcano-Ponce (10.1016/j.heliyon.2024.e35906_bib4) 2001; 51 Gbolahan (10.1016/j.heliyon.2024.e35906_bib23) 2024; 7 Yu (10.1016/j.heliyon.2024.e35906_bib29) 2015; 7 Ferrer (10.1016/j.heliyon.2024.e35906_bib8) 2024 Frankish (10.1016/j.heliyon.2024.e35906_bib9) 2023; 51 Wang (10.1016/j.heliyon.2024.e35906_bib20) 2017; 13 Su (10.1016/j.heliyon.2024.e35906_bib22) 2021; 38 Li (10.1016/j.heliyon.2024.e35906_bib24) 2020; 12 Roa (10.1016/j.heliyon.2024.e35906_bib1) 2022; 8 Feng (10.1016/j.heliyon.2024.e35906_bib21) 2022; 18 Batista (10.1016/j.heliyon.2024.e35906_bib12) 2013; 152 Zhuang (10.1016/j.heliyon.2024.e35906_bib15) 2019; 39 Stinton (10.1016/j.heliyon.2024.e35906_bib3) 2012; 6 Jiang (10.1016/j.heliyon.2024.e35906_bib16) 2020; 235 Zhang (10.1016/j.heliyon.2024.e35906_bib30) 2019; 128 Fu (10.1016/j.heliyon.2024.e35906_bib26) 2021; 26 Lu (10.1016/j.heliyon.2024.e35906_bib27) 2021; 11 Akhtar (10.1016/j.heliyon.2024.e35906_bib5) 2020; 20 Guo (10.1016/j.heliyon.2024.e35906_bib28) 2019; 54 Xing (10.1016/j.heliyon.2024.e35906_bib17) 2021; 49 Liu (10.1016/j.heliyon.2024.e35906_bib19) 2020; 11 Rinn (10.1016/j.heliyon.2024.e35906_bib10) 2012; 81 Balakrishnan (10.1016/j.heliyon.2024.e35906_bib2) 2023; 59 Shindoh (10.1016/j.heliyon.2024.e35906_bib6) 2015; 261 Kanthan (10.1016/j.heliyon.2024.e35906_bib7) 2015; 2015 |
| References_xml | – volume: 59 year: 2023 ident: bib2 article-title: Surgical outcomes of gallbladder cancer: the omega retrospective, multicentre, international cohort study publication-title: EClinicalMedicine – volume: 499 start-page: 425 year: 2018 end-page: 432 ident: bib18 article-title: Induction of mek/erk activity by azd8055 confers acquired resistance in neuroblastoma publication-title: Biochem. Biophys. Res. Commun. – volume: 7 year: 2024 ident: bib23 article-title: Adjuvant chemotherapy and outcomes in older adult patients with biliary tract cancer publication-title: JAMA Netw. Open – volume: 51 start-page: D942 year: 2023 end-page: D949 ident: bib9 article-title: Gencode: reference annotation for the human and mouse genomes in 2023 publication-title: Nucleic Acids Res. – volume: 2015 year: 2015 ident: bib7 article-title: Gallbladder cancer in the 21st century publication-title: J Oncol – volume: 11 start-page: 5466 year: 2020 end-page: 5477 ident: bib19 article-title: Dgcr5 promotes gallbladder cancer by sponging mir-3619-5p via mek/erk1/2 and jnk/p38 mapk pathways publication-title: J. Cancer – volume: 54 start-page: 807 year: 2019 end-page: 820 ident: bib28 article-title: Microrna98 suppresses cell growth and invasion of retinoblastoma via targeting the igf1r/kras/raf/mek/erk signaling pathway publication-title: Int. J. Oncol. – volume: 28 start-page: 287 year: 2018 end-page: 301 ident: bib13 article-title: Long noncoding rna in cancer: wiring signaling circuitry publication-title: Trends Cell Biol. – volume: 8 start-page: 69 year: 2022 ident: bib1 article-title: Gallbladder cancer publication-title: Nat. Rev. Dis. Prim. – volume: 18 start-page: 473 year: 2022 end-page: 490 ident: bib21 article-title: Id09, a newly-designed tubulin inhibitor, regulating the proliferation, migration, emt process and apoptosis of oral squamous cell carcinoma publication-title: Int. J. Biol. Sci. – volume: 51 start-page: 349 year: 2001 end-page: 364 ident: bib4 article-title: Epidemiology and molecular pathology of gallbladder cancer publication-title: CA Cancer J Clin – volume: 12 start-page: 12983 year: 2020 end-page: 12992 ident: bib24 article-title: Long non-coding rna oip5-as1 contributes to gallbladder cancer cell invasion and migration by mir-143-3p suppression publication-title: Cancer Manag. Res. – volume: 117 start-page: 245 year: 2017 end-page: 255 ident: bib31 article-title: Kif15 promotes pancreatic cancer proliferation via the mek-erk signalling pathway publication-title: Br. J. Cancer – volume: 235 start-page: 7194 year: 2020 end-page: 7203 ident: bib16 article-title: Lncrna hoxb-as3 exacerbates proliferation, migration, and invasion of lung cancer via activating the pi3k-akt pathway publication-title: J. Cell. Physiol. – volume: 68 start-page: 171 year: 2017 end-page: 184 ident: bib14 article-title: A peptide encoded by a putative lncrna hoxb-as3 suppresses colon cancer growth publication-title: Mol Cell – volume: 17 start-page: 47 year: 2016 end-page: 62 ident: bib11 article-title: Unique features of long non-coding rna biogenesis and function publication-title: Nat. Rev. Genet. – volume: 11 year: 2021 ident: bib27 article-title: Long non-coding rna linc01410 promoted tumor progression via the erbb signaling pathway by targeting stat5 in gallbladder cancer publication-title: Front. Oncol. – volume: 20 start-page: 1175 year: 2020 ident: bib5 article-title: Immunoproteomics approach revealed elevated autoantibody levels against anxa1 in early stage gallbladder carcinoma publication-title: BMC Cancer – volume: 81 start-page: 145 year: 2012 end-page: 166 ident: bib10 article-title: Genome regulation by long noncoding rnas publication-title: Annu. Rev. Biochem. – volume: 13 start-page: 3508 year: 2017 end-page: 3516 ident: bib20 article-title: Long non-coding rna expression profiles in gallbladder carcinoma identified using microarray analysis publication-title: Oncol. Lett. – volume: 152 start-page: 1298 year: 2013 end-page: 1307 ident: bib12 article-title: Long noncoding rnas: cellular address codes in development and disease publication-title: Cell – volume: 39 year: 2019 ident: bib15 article-title: Overexpression of long noncoding rna hoxb-as3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via wnt/beta-catenin signaling pathway publication-title: Biosci. Rep. – volume: 6 start-page: 172 year: 2012 end-page: 187 ident: bib3 article-title: Epidemiology of gallbladder disease: cholelithiasis and cancer publication-title: Gut Liver – volume: 28 start-page: 306 year: 2021 end-page: 318 ident: bib25 article-title: Silencing of long non-coding rna foxd2-as1 inhibits the progression of gallbladder cancer by mediating methylation of mlh1 publication-title: Gene Ther. – volume: 49 year: 2021 ident: bib17 article-title: Long non-coding rna (lncrna) hoxb-as3 promotes cell proliferation and inhibits apoptosis by regulating adam9 expression through targeting mir-498-5p in endometrial carcinoma publication-title: J. Int. Med. Res. – volume: 7 start-page: 269 year: 2015 end-page: 289 ident: bib29 article-title: The raf-mek-erk pathway: targeting erk to overcome obstacles to effective cancer therapy publication-title: Future Med. Chem. – year: 2024 ident: bib8 article-title: Transcription regulation by long non-coding rnas: mechanisms and disease relevance publication-title: Nat. Rev. Mol. Cell Biol. – volume: 26 year: 2021 ident: bib26 article-title: Lncrna epic1 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by interacting with let publication-title: Ann. Hepatol. – volume: 261 start-page: 733 year: 2015 end-page: 739 ident: bib6 article-title: Tumor location is a strong predictor of tumor progression and survival in t2 gallbladder cancer: an international multicenter study publication-title: Ann. Surg. – volume: 38 start-page: 141 year: 2021 ident: bib22 article-title: Identification of cell cycle as the critical pathway modulated by exosome-derived micrornas in gallbladder carcinoma publication-title: Med. Oncol. – volume: 128 start-page: 574 year: 2019 end-page: 582 ident: bib30 article-title: Ribophorin ii potentiates p-glycoprotein- and abcg2-mediated multidrug resistance via activating erk pathway in gastric cancer publication-title: Int. J. Biol. Macromol. – volume: 17 start-page: 47 year: 2016 ident: 10.1016/j.heliyon.2024.e35906_bib11 article-title: Unique features of long non-coding rna biogenesis and function publication-title: Nat. Rev. Genet. doi: 10.1038/nrg.2015.10 – volume: 38 start-page: 141 year: 2021 ident: 10.1016/j.heliyon.2024.e35906_bib22 article-title: Identification of cell cycle as the critical pathway modulated by exosome-derived micrornas in gallbladder carcinoma publication-title: Med. Oncol. doi: 10.1007/s12032-021-01594-8 – volume: 68 start-page: 171 year: 2017 ident: 10.1016/j.heliyon.2024.e35906_bib14 article-title: A peptide encoded by a putative lncrna hoxb-as3 suppresses colon cancer growth publication-title: Mol Cell doi: 10.1016/j.molcel.2017.09.015 – volume: 28 start-page: 287 year: 2018 ident: 10.1016/j.heliyon.2024.e35906_bib13 article-title: Long noncoding rna in cancer: wiring signaling circuitry publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2017.11.008 – volume: 6 start-page: 172 year: 2012 ident: 10.1016/j.heliyon.2024.e35906_bib3 article-title: Epidemiology of gallbladder disease: cholelithiasis and cancer publication-title: Gut Liver doi: 10.5009/gnl.2012.6.2.172 – volume: 12 start-page: 12983 year: 2020 ident: 10.1016/j.heliyon.2024.e35906_bib24 article-title: Long non-coding rna oip5-as1 contributes to gallbladder cancer cell invasion and migration by mir-143-3p suppression publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S278719 – volume: 51 start-page: D942 year: 2023 ident: 10.1016/j.heliyon.2024.e35906_bib9 article-title: Gencode: reference annotation for the human and mouse genomes in 2023 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac1071 – volume: 39 year: 2019 ident: 10.1016/j.heliyon.2024.e35906_bib15 article-title: Overexpression of long noncoding rna hoxb-as3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via wnt/beta-catenin signaling pathway publication-title: Biosci. Rep. doi: 10.1042/BSR20190906 – volume: 499 start-page: 425 year: 2018 ident: 10.1016/j.heliyon.2024.e35906_bib18 article-title: Induction of mek/erk activity by azd8055 confers acquired resistance in neuroblastoma publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.03.143 – volume: 26 year: 2021 ident: 10.1016/j.heliyon.2024.e35906_bib26 article-title: Lncrna epic1 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by interacting with let publication-title: Ann. Hepatol. doi: 10.1016/j.aohep.2021.100563 – volume: 13 start-page: 3508 year: 2017 ident: 10.1016/j.heliyon.2024.e35906_bib20 article-title: Long non-coding rna expression profiles in gallbladder carcinoma identified using microarray analysis publication-title: Oncol. Lett. doi: 10.3892/ol.2017.5893 – volume: 11 start-page: 5466 year: 2020 ident: 10.1016/j.heliyon.2024.e35906_bib19 article-title: Dgcr5 promotes gallbladder cancer by sponging mir-3619-5p via mek/erk1/2 and jnk/p38 mapk pathways publication-title: J. Cancer doi: 10.7150/jca.46351 – volume: 49 year: 2021 ident: 10.1016/j.heliyon.2024.e35906_bib17 article-title: Long non-coding rna (lncrna) hoxb-as3 promotes cell proliferation and inhibits apoptosis by regulating adam9 expression through targeting mir-498-5p in endometrial carcinoma publication-title: J. Int. Med. Res. doi: 10.1177/03000605211013548 – volume: 11 year: 2021 ident: 10.1016/j.heliyon.2024.e35906_bib27 article-title: Long non-coding rna linc01410 promoted tumor progression via the erbb signaling pathway by targeting stat5 in gallbladder cancer publication-title: Front. Oncol. – volume: 128 start-page: 574 year: 2019 ident: 10.1016/j.heliyon.2024.e35906_bib30 article-title: Ribophorin ii potentiates p-glycoprotein- and abcg2-mediated multidrug resistance via activating erk pathway in gastric cancer publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2019.01.195 – volume: 28 start-page: 306 year: 2021 ident: 10.1016/j.heliyon.2024.e35906_bib25 article-title: Silencing of long non-coding rna foxd2-as1 inhibits the progression of gallbladder cancer by mediating methylation of mlh1 publication-title: Gene Ther. doi: 10.1038/s41434-020-00187-w – year: 2024 ident: 10.1016/j.heliyon.2024.e35906_bib8 article-title: Transcription regulation by long non-coding rnas: mechanisms and disease relevance publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-023-00694-9 – volume: 7 year: 2024 ident: 10.1016/j.heliyon.2024.e35906_bib23 article-title: Adjuvant chemotherapy and outcomes in older adult patients with biliary tract cancer publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2023.51502 – volume: 7 start-page: 269 year: 2015 ident: 10.1016/j.heliyon.2024.e35906_bib29 article-title: The raf-mek-erk pathway: targeting erk to overcome obstacles to effective cancer therapy publication-title: Future Med. Chem. doi: 10.4155/fmc.14.143 – volume: 59 year: 2023 ident: 10.1016/j.heliyon.2024.e35906_bib2 article-title: Surgical outcomes of gallbladder cancer: the omega retrospective, multicentre, international cohort study publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2023.101951 – volume: 2015 year: 2015 ident: 10.1016/j.heliyon.2024.e35906_bib7 article-title: Gallbladder cancer in the 21st century publication-title: J Oncol doi: 10.1155/2015/967472 – volume: 81 start-page: 145 year: 2012 ident: 10.1016/j.heliyon.2024.e35906_bib10 article-title: Genome regulation by long noncoding rnas publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev-biochem-051410-092902 – volume: 51 start-page: 349 year: 2001 ident: 10.1016/j.heliyon.2024.e35906_bib4 article-title: Epidemiology and molecular pathology of gallbladder cancer publication-title: CA Cancer J Clin – volume: 235 start-page: 7194 year: 2020 ident: 10.1016/j.heliyon.2024.e35906_bib16 article-title: Lncrna hoxb-as3 exacerbates proliferation, migration, and invasion of lung cancer via activating the pi3k-akt pathway publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29618 – volume: 8 start-page: 69 year: 2022 ident: 10.1016/j.heliyon.2024.e35906_bib1 article-title: Gallbladder cancer publication-title: Nat. Rev. Dis. Prim. doi: 10.1038/s41572-022-00398-y – volume: 54 start-page: 807 year: 2019 ident: 10.1016/j.heliyon.2024.e35906_bib28 article-title: Microrna98 suppresses cell growth and invasion of retinoblastoma via targeting the igf1r/kras/raf/mek/erk signaling pathway publication-title: Int. J. Oncol. – volume: 261 start-page: 733 year: 2015 ident: 10.1016/j.heliyon.2024.e35906_bib6 article-title: Tumor location is a strong predictor of tumor progression and survival in t2 gallbladder cancer: an international multicenter study publication-title: Ann. Surg. doi: 10.1097/SLA.0000000000000728 – volume: 152 start-page: 1298 year: 2013 ident: 10.1016/j.heliyon.2024.e35906_bib12 article-title: Long noncoding rnas: cellular address codes in development and disease publication-title: Cell doi: 10.1016/j.cell.2013.02.012 – volume: 20 start-page: 1175 year: 2020 ident: 10.1016/j.heliyon.2024.e35906_bib5 article-title: Immunoproteomics approach revealed elevated autoantibody levels against anxa1 in early stage gallbladder carcinoma publication-title: BMC Cancer doi: 10.1186/s12885-020-07676-6 – volume: 18 start-page: 473 year: 2022 ident: 10.1016/j.heliyon.2024.e35906_bib21 article-title: Id09, a newly-designed tubulin inhibitor, regulating the proliferation, migration, emt process and apoptosis of oral squamous cell carcinoma publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.65824 – volume: 117 start-page: 245 year: 2017 ident: 10.1016/j.heliyon.2024.e35906_bib31 article-title: Kif15 promotes pancreatic cancer proliferation via the mek-erk signalling pathway publication-title: Br. J. Cancer doi: 10.1038/bjc.2017.165 |
| SSID | ssj0001586973 |
| Score | 2.2874243 |
| Snippet | LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains... Background: LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e35906 |
| SubjectTerms | agonists apoptosis cancer therapy carcinogenesis carcinoma cell proliferation cell viability flow cytometry gall bladder Gallbladder carcinoma HOXB-AS3 interphase Long non coding RNA MEK/ERK metastasis neoplasm cells neoplasm progression phosphorylation quantitative polymerase chain reaction xenotransplantation |
| Title | LncRNA HOXB-AS3 promotes proliferation, migration, and invasion of gallbladder cancer cells by activating the MEK/ERK pathway |
| URI | https://dx.doi.org/10.1016/j.heliyon.2024.e35906 https://www.ncbi.nlm.nih.gov/pubmed/39224245 https://www.proquest.com/docview/3100271990 https://www.proquest.com/docview/3154155458 https://pubmed.ncbi.nlm.nih.gov/PMC11367030 https://doaj.org/article/3119f8a5ea2d429eb0be221a357f33ff |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQkBAviG_KYDISj6RN4jiJHzvUqaJ0SIWJvll2fN4yZe60dkN94H_Hl4_SgkRfeEqU2Ensu_h-Z59_R8h7jxGE1SYNdMbAOygiD3LNIRCAqS0shHmBE_rT03R8lnya8_lWqi-MCWvogZuOG7AoEjZXHFRs_NgJOtQQx5FiPLOMWYujr7d5W85Usz84T0XGfm_ZGVz2L6Aq1wvkPI2TPjAuMMvRljGqOft3bNLfmPPP0MktW3TymDxqQSQdNh__hNwD95Q8mLbL5M_Iz8-umJ0O6fjL_DgYfmX0ug66gyWeVBjMUsvjA70qz7tT5Qwt3Z3C2TO6sBRX5HWF49INLVA1_AGqakn1muJmCJzKdefU40c6HU0Go9mEYnbjH2r9nJydjL59HAdtnoWg4Gm2CrjOtEImKeGNvcoMi5gJVSIss6HQlqUAAoxCIhxtwGrOjVGpNlwnRWYVYy_IgVs4eEWo9b55rFPr_TCDnlrObaQKzmLA1H9F2CNJ1-GyaEnIMRdGJbtos0vZykminGQjpx7pb6pdNywc-yocozQ3hZFEu77gVUu2qiX3qVaP5J0uyBaPNDjDP6rc9_53ne5I_7-ifJSDxe1S4oJKnEUeBPyrDK9xHs975GWjb5uWeDyLO3q4_7gdTdxp6u4dV17UvOGYvgcH-Nf_o3MOyUNsbz29Hr4hB6ubW3jr8dlKH5H7w8ns--So_iV_Ad18PXs |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNA+HOXB-AS3+promotes+proliferation%2C+migration%2C+and+invasion+of+gallbladder+cancer+cells+by+activating+the+MEK%2FERK+pathway&rft.jtitle=Heliyon&rft.au=Wu%2C+Jiayan&rft.au=Yu%2C+Jiandong&rft.au=Zhu%2C+Hongquan&rft.au=Chen%2C+Zhiping&rft.date=2024-08-30&rft.pub=Elsevier&rft.eissn=2405-8440&rft.volume=10&rft.issue=16&rft_id=info:doi/10.1016%2Fj.heliyon.2024.e35906&rft.externalDocID=PMC11367030 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon |